Senior Scientist T-cell Receptor Discovery (f/m/d)

Immatics is a clinical-stage biopharmaceutical company active in the discovery and development of T-cell redirecting immunotherapies for the treatment of cancer. The Company’s transformative product candidates are Adoptive Cell Therapies (e.g. ACTengine®) and Bispecific TCR molecules (e.g. TCER®). These products are directed against tumor targets that have been identified and validated by Immatics’ proprietary and world-leading XPRESIDENT® technology. Operating from Tuebingen, Munich and Houston, the Company has recognized that novel, better and safer targets are the key to developing future cancer immunotherapies and it is Immatics’ mission to deliver the power of T cells to cancer patients. For more detailed information, visit www.immatics.com.

We are currently seeking a
 
Senior Scientist T-cell Receptor Discovery (f/m/d)


to support our team in the discovery and preclinical assessment of novel cancer-specific T-cell receptors (TCRs).

The team TCR Discovery and Validation isolates TCRs recognizing proprietary tumor antigens from blood products of healthy individuals. After isolation, TCRs are re-expressed in human cells and extensively characterized. In the end, suitable candidates for either adoptive cell therapy or soluble TCR bispecifics are tested preclinically for efficacy and safety by our team.

Activities and responsibilities

  • Identification and characterization of TCRs for novel proprietary tumor targets
  • Method development in the context of TCR discovery
  • Professional leadership and management of lab operations and staff
  • Project management for allocated tasks
  • Contribution to and revision of Standard Operating Procedures (SOPs)
  • Contribution to the filing of regulatory documents

Qualification profile

  • PhD degree in Life Sciences  
  • Postdoctoral experience or/ and 2+ years pharmaceutical/ biotech industry experience
  • Strong background in molecular biology and immunology
  • A solid research record demonstrated by publications, patents or presentations in immunology, tumor-oncology or related areas, most preferably in the context of TCR biology
  • Experience with basic molecular biology techniques is mandatory, experience with cell-based functional assays and multicolor flow cytometry is preferred
  • Excellent communication skills in English and German


We expect a high degree of independent working and analytical reasoning. Your motivation is driven by your dedication to innovation and science. You take careful editing and documenting of your results for granted. You approach tasks in a structured, reliable and foresighted manner, combined with an elevated level of individual responsibility, enthusiasm and strong social skills.

We offer

You will work in Tuebingen in an interdisciplinary environment with scientists from all R&D departments, Business Development and Intellectual Property. We are a committed and inspired team and cherish the collegial, highly motivated and family-friendly atmosphere within Immatics. Our culture allows for a high degree of originality, independent thinking and initiative. We believe in supporting our employees’ professional and social skills: We enable them to join conferences and trainings as well as to enjoy our Immatics benefits – e.g. job bike, childcare benefits, Health Programs, relocation allowance.

Send application to

If you’re interested in working for Immatics, please apply online and provide your application documents along with the relevant credentials and certificates.

Mrs Annemarie Selbenbacher will answer initial questions at +49 89 125 03 98 33 (landline number Germany). Coredi Recruiting (Mrs Annemarie Selbenbacher) advises Immatics on this job posting.

Bitte beziehen Sie sich bei Ihrer Bewerbung auf jobvector und geben Sie die folgende Referenznummer an: jv-1508

Über Immatics Biotechnologies GmbH

Immatics Biotechnologies GmbH   Immatics Biotechnologies GmbH ist ein unabhängiges biopharmazeutisches Unternehmen mit Sitz in Tübingen und München, das aktive Immuntherapien gegen Krebs entwickelt. Die therapeutischen Impfstoffe von immatics basieren auf Kombinationen mehrerer tumor-assoziierter Peptide (TUMAPs), die das Immunsystem gezielt gegen...
Mehr über Immatics Biotechnologies GmbH

Vergütung

Die Vergütung für vergleichbare Positionen liegt im Mittel bei circa 54.362,00 € brutto im Jahr. Je nach Erfahrung und Qualifikation, sowie weiteren Faktoren kann dieser Schätzwert in unterschiedlichem Maße von der tatsächlich zu erwartenden Vergütung abweichen. Weitere Informationen zu Gehalt und Gehaltsverhandlung finden Sie in unserem Karriereratgeber.